Pharmaceutical - Markets & Marketing, Pharmaceutical

Filter

Popular Filters

1 to 25 of 1109 results

Ablynx out-licenses ozoralizumab for Greater China to Eddingpharm

Ablynx out-licenses ozoralizumab for Greater China to Eddingpharm

01-09-2014

Belgian drug developer Ablynx has expanded its relationship with China’s Eddingpharm, by granting the…

AblynxAnti-Arthritics/RheumaticsChinaEddingpharmLicensingMarkets & MarketingozoralizumabPharmaceutical

Colorectal cancer market will remain steady at $7.7 billion by 2023; report

29-08-2014

The market for colorectal cancer (CRC) therapies will remain constant, at around $7.7 billion by 2023…

EuropeJapanMarkets & MarketingOncologyPharmaceuticalUSA

Daiichi Sankyo links with Kaketsuken for Bimmugen sales

28-08-2014

Japanese drug major Daiichi Sankyo has signed a cooperative sales agreement with The Chemo-Sero-Therapeutic…

Anti-viralsBimmugenDaiichi SankyoJapanKaketsukenLicensingMarkets & MarketingPharmaceuticalVaccines

Strong growth forecast for glioblastoma multiforme therapeutics in Asia-Pacific

Strong growth forecast for glioblastoma multiforme therapeutics in Asia-Pacific

26-08-2014

The glioblastoma multiforme therapeutics market in the four Asia-Pacific markets of Australia, China,…

Asia-PacificAustraliaAvastinCelldex TherapeuticsChinaCotaraIndiaJapanMarkets & MarketingOncologyPeregrine PharmaceuticalsPharmaceuticalrindopepimutRoche

Globavir to seek approval and launch of novel Ebola treatment by year-end

Globavir to seek approval and launch of novel Ebola treatment by year-end

19-08-2014

Privately-held US biotech firm Globavir Biosciences said yesterday that it intends to develop its lead…

Antibiotics and Infectious diseasesGBV006Globavir BiosciencesMarkets & MarketingPharmaceuticalRegulationRest of the WorldTropical diseasesUSA

Belsomra could become first-line insomnia therapy, says GlobalData

Belsomra could become first-line insomnia therapy, says GlobalData

18-08-2014

Insomnia treatment Belsomra (suvorexant) from US pharma giant Merck & Co has the potential to become…

BelsomraChemistryCyclopyrrolonesInsomniaMarkets & MarketingMerck & CoNeurologicalOrganic chemistryPharmaceuticalUSA

Turkish man pleads guilty to importing illegal cancer drugs into USA

Turkish man pleads guilty to importing illegal cancer drugs into USA

17-08-2014

Sabahaddin Akman, owner of the Istanbul, Turkey, firm Ozay Pharmaceuticals, has pleaded guilty to charges…

AvastinLegalMarkets & MarketingOncologyOzay PharmaceuticalsPharmaceuticalRituxanSabahaddin AkmanTurkeyUSA

New treatments will partially compensate for unipolar depression drugs coming out of patent

New treatments will partially compensate for unipolar depression drugs coming out of patent

14-08-2014

New antidepressants and antipsychotics will offset a steep decline in sales following genericization…

Antidepressant therapiesDecision Resources GroupGlobalMarkets & MarketingNeurologicalPharmaceuticalPsychiatryUnipolar depression

Global asthma market to hit $18 billion by 2021 boosted by biologics

Global asthma market to hit $18 billion by 2021 boosted by biologics

14-08-2014

The market for asthma drugs is predicted to reach $18 billion by 2021, according to new research from…

AdvairAsthmaAstraZenecaBoehringer IngelheimBreoGlaxoSmithKlineGlobalMarkets & MarketingNatasha SpillerPharmaceuticalRespiratory and PulmonaryRespiratory therapySpirivaSymbicort

Asia Healthcare Forum identifies challenges ahead for meetings in the sector

Asia Healthcare Forum identifies challenges ahead for meetings in the sector

13-08-2014

The inaugural Healthcare Meetings Forum Asia was over-subscribed on August 1 at Suntec Singapore, an…

Asia-PacificMarkets & MarketingPharmaceuticalRegulationSingapore

Strong growth forecast for Saudi Arabia pharmaceuticals market

Strong growth forecast for Saudi Arabia pharmaceuticals market

13-08-2014

Pharmaceuticals products sales in Saudi Arabia are expected to exceed a value of $ 7 billion by 2018,…

Business FinanceFinancialMarkets & MarketingPharmaceuticalProductionRest of the WorldSaudi Arabia

Ukraine may face drugs shortage this year

Ukraine may face drugs shortage this year

11-08-2014

Ukraine plans to ban pharmaceutical imports from Russia, except 20 vital drugs, the analogues of which…

Markets & MarketingPharmaceuticalPoliticsPricingRussiaUkraine

Imatinib and sunitinib will continue to dominate patient share in GIST treatment

Imatinib and sunitinib will continue to dominate patient share in GIST treatment

11-08-2014

The treatment landscape of gastrointestinal stromal tumors (GIST) will not change dramatically through…

BayerGleevecGlivecMarkets & MarketingNovartisOncologyPfizerPharmaceuticalStivargaSutent

Russia may restrict drug imports from Western countries

Russia may restrict drug imports from Western countries

11-08-2014

The Russian Federation Council, the upper house of the Federal Assembly of the country, has put forward…

Drug safetyHealthcareMarkets & MarketingPharmaceuticalPoliticsRussia

Brazil's pharma market has potential for 10% annual growth

Brazil's pharma market has potential for 10% annual growth

11-08-2014

Brazil’s pharma market has the potential to grow by more than 10% per year, according to the head of…

BrazilMarkets & MarketingPharmaceuticalPharmaceutical industry

Belgian pharma trade body issues recommendations on domestic drug shortages

Belgian pharma trade body issues recommendations on domestic drug shortages

11-08-2014

Belgium’s pharmaceutical trade body, pharma.be, has issued a conclusion of its report on the shortage…

BelgiumMarkets & MarketingPharmaceuticalRegulation

MS market to reach $20 billion in 2023 boosted by five new therapies

MS market to reach $20 billion in 2023 boosted by five new therapies

08-08-2014

The forecast launch of five immunomodulatory therapies for relapsing forms of multiple sclerosis will…

CNS DiseasesEuropeImmunosuppressantsJapanMarkets & MarketingMSPharmaceuticalUSA

Nicox and Bausch + Lomb to co-promote latanoprostene bunod for glaucoma

Nicox and Bausch + Lomb to co-promote latanoprostene bunod for glaucoma

08-08-2014

International opthalmic company Nicox is to co-promote latanoprostene bunod with Bausch + Lomb, the eyecare…

Bausch & LombCanadaGlaucomaLatanoprost OphthalmicMarkets & MarketingNicOxOphthalmicsOpticsPharmaceuticalUSA

Mexico’s health care market to reach almost $28 billion by 2020

Mexico’s health care market to reach almost $28 billion by 2020

07-08-2014

Mexico’s pharmaceutical and medical devices industries will be worth around $22.5 billion and $5.4…

Business FinanceMarkets & MarketingMexicoNon-communicable diseasesPharmaceuticalPharmaceutical and medical devices industriesPharmacologyPharmacy

Access and Norgine to partner on MuGard in European territories

Access and Norgine to partner on MuGard in European territories

07-08-2014

Emerging biopharma company Access Pharmaceuticals has entered into an exclusive license agreement with…

Access PharmaceuticalsAccess Pharmaceuticals, Inc.AnalgesiaEuropeMarkets & MarketingMucositisMuGardNorginePharmaceutical

Lilly and Boehringer closing in on diabetes market lead with Jardiance approval

Lilly and Boehringer closing in on diabetes market lead with Jardiance approval

07-08-2014

With the recent approval of Jardiance (empagliflozin) in the USA, Eli Lilly and its partner, German family-owned…

Boehringer IngelheimDiabetesEli LillyEli Lilly and CompanyJanuviaJardianceMarkets & MarketingMerck & CoPharmaceuticalTradjenta

Sanofi partners with Emcure for oncology portfolio in India

Sanofi partners with Emcure for oncology portfolio in India

06-08-2014

French pharma major Sanofi’s Indian subsidiary said today that it has entered into a marketing and…

Emcure PharmaceuticalsFasturtecFludaraIndiaJevtanaMarkets & MarketingOncologyPharmaceuticalSanofiTaxotere

Walgreens to buy remainder of Boots Alliance, but shuns inversion

06-08-2014

US pharmacy giant Walgreen has exercised its option to buy the remaining 55% of European pharmacy retailer…

Alliance BootsEuropeMarkets & MarketingMergers & AcquisitionsPharmaceuticalWalgreens

Existing diabetes drug Victoza could be effective treatment for world’s obese

Existing diabetes drug Victoza could be effective treatment for world’s obese

06-08-2014

Pharmaceutical companies are racing to find a new form of obesity drug as patient numbers spiral and…

Anti-diabetic drugsDiabetesGastro-intestinalsGlobalMarkets & MarketingNovo NordiskPeptide hormonesPharmaceuticalVictoza

1 to 25 of 1109 results

Back to top